Barry Kramer receives Friendship Award from the People’s Republic of China

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Barry Kramer

Barry Kramer, former director of the NCI Division of Cancer Prevention, has received the People’s Republic of China Friendship Award, the highest honor given to non-citizens.

Kramer received the award on Sept. 30 for his work with the National Cancer Center of China, part of the Cancer Institute of the Chinese Academy of Medical Sciences. This year, he was one of 14 Americans to receive the award, and one of two health care professionals out of 100 awardees from 31 countries. The award has been given annually since 1991.

Kramer was nominated by the National Cancer Center for designing cancer screening studies and his leadership in translating NCI’s Physician Data Query into Chinese. The PDQ has been translated into Spanish, Japanese and Arabic.

From NCI, Margaret Beckwith, acting branch chief for the PDQ Cancer Information Branch; Martina Vogel Taylor; Ping Hu; Philip Prorok; Richard Fagerstrom; and Paul Pinsky, all in the Division of Cancer Prevention, were central to the collaboration with the People’s Republic of China. From China, He Jie, director of National Cancer Center of China, and Dai Min, also of NCC, worked with the NCI team.

Kramer retired from NCI in 2019 (The Cancer Letter, Nov. 2, 2018). He is a consultant in the NCI Division of Cancer Control and Population Sciences and an honorary professor at the National Cancer Center.

Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login